Shigeki Shimasaki, Tomohisa Baba, Takashi Ogura, Keiichi Akasaka, Hidekazu Matsushima, Shinyu Izumi, Jin Takasaki, Kenji Tsushima, Toru Kinouchi, Yoshiko Kichikawa, Maiko Awashima, Takehiro Izumo, Nobuyasu Awano, Naoki Nishimura, Ryushi Tazawa, Ayako Mikami, Nobutaka Kitamura, Haruyuki Ishii, Yasuyuki Kurihara, Masaki Taniguchi, Satoko Aikawa, Mami Okada, Yusuke Morita, Yuko Ishikawa, Akira Ohinata, Koh Nakata
BACKGROUND: Granulocyte-macrophage colony stimulating factor (GM-CSF) inhalation may alleviate pulmonary inflammation caused by viral pneumonia. To investigate this, we evaluated its efficacy on COVID-19 pneumonia. METHODS: This double-blind, randomised, placebo-controlled study (ClinicalTrials.gov: NCT04642950) evaluated patients in the first half of 2021 at seven Japanese hospitals. Hospitalised patients with COVID-19 pneumonia with moderate hypoxaemia inhaled sargramostim or placebo for 5 days...
September 20, 2023: Infectious Diseases